Maternal Height and Infant Body Mass Index Are Possible Risk Factors for Developmental Dysplasia of the Hip in Female

Hakan Atalar1, Cuneyd Gunay, Osman Yuksel Yavuz

  • 1Departments of Orthopaedics and Traumatology, Gazi University School of Medicine, Ankara 06500, Turkey.

Acta Medica Okayama
|December 23, 2015
PubMed

Insights

Short maternal height and a low maternal height to infant BMI ratio are significant risk factors for developmental dysplasia of the hip (DDH). These findings highlight potential new indicators for identifying infants at risk of DDH.

Area of Science:

  • Orthopedics
  • Pediatrics
  • Genetics

Background:

  • Developmental dysplasia of the hip (DDH) is a common condition with complex causes.
  • The exact etiology of DDH remains unclear despite its prevalence.

Purpose of the Study:

  • To identify novel risk factors for DDH.
  • To evaluate maternal and infant anthropometric measurements as potential predictors of DDH.

Main Methods:

  • A case-control study involving 71 female first-born infants (28 with DDH, 43 healthy).
  • Maternal pre-pregnancy height/weight and infant birth height/weight/BMI were recorded.
  • Ratios between maternal and infant parameters were calculated.

Main Results:

  • Short maternal height was significantly associated with DDH.
  • A low maternal height to infant BMI ratio (MH/I-BMI) was also a significant risk factor for DDH.

Conclusions:

  • Maternal stature and the MH/I-BMI ratio may serve as important indicators for DDH risk.
  • Further research with larger cohorts is needed to validate these findings.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
70.4K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.9K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
21
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K